FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976490669> ?p ?o ?g. }

• W1976490669 endingPage "522" @default.
• W1976490669 startingPage "513" @default.
• W1976490669 abstract "Purpose Age-related macular degeneration (AMD) is the leading cause of blindness among older adults, in which oxidative damage may play a pivotal role. Paraoxonase 1 (PON1) protects against oxidative damage and has been evaluated for its involvement in aging diseases including AMD. This study investigated whether PON1 gene polymorphisms associate with AMD. Design Case-control association study. Methods We studied 1037 individuals with AMD subcategorized using AREDS criteria and 370 control subjects without retinal disease. Participants were primarily Caucasian of European descent. All exons of PON1 were evaluated by single-strand conformation polymorphism and direct sequence analysis. Results Six missense changes (Leu55Met, Met127Arg, His155Arg, Gln192Arg, Gln192Glu, Ala252Gly) were identified in PON1. We observed a weak association of Leu55Met with an increased risk of wet AMD (P = .02), but not with dry AMD or when combining all patient categories. A significantly higher allele frequency for Gln192Arg was detected in controls than in the combined AMD patient population (P < .0001), and when category 2, 3, and 4 patients were separately considered (P = .004, P = .002, and P < .0001, respectively). For category 4 AMD, the Arg192 allele was significantly less prevalent in the wet form (P < .0001), but not in the dry form (P = .377). Conclusion We report a weak association of PON1 Leu55Met with an increased risk of wet AMD, replicating previous reports. Our findings indicate a protective role for Gln192Arg, particularly for patients with the wet form. Gln192Glu warrants consideration, as this variant alters the same amino acid as Gln192Arg and was identified only in category 4 AMD patients. We believe that Met127Arg, His155Arg, and Ala252Gly play minor roles in AMD susceptibility because of their limited frequency and/or location within the PON1 gene. The functional and biological mechanism by which Gln192Arg is acting to decrease AMD susceptibility remains to be determined. Age-related macular degeneration (AMD) is the leading cause of blindness among older adults, in which oxidative damage may play a pivotal role. Paraoxonase 1 (PON1) protects against oxidative damage and has been evaluated for its involvement in aging diseases including AMD. This study investigated whether PON1 gene polymorphisms associate with AMD. Case-control association study. We studied 1037 individuals with AMD subcategorized using AREDS criteria and 370 control subjects without retinal disease. Participants were primarily Caucasian of European descent. All exons of PON1 were evaluated by single-strand conformation polymorphism and direct sequence analysis. Six missense changes (Leu55Met, Met127Arg, His155Arg, Gln192Arg, Gln192Glu, Ala252Gly) were identified in PON1. We observed a weak association of Leu55Met with an increased risk of wet AMD (P = .02), but not with dry AMD or when combining all patient categories. A significantly higher allele frequency for Gln192Arg was detected in controls than in the combined AMD patient population (P < .0001), and when category 2, 3, and 4 patients were separately considered (P = .004, P = .002, and P < .0001, respectively). For category 4 AMD, the Arg192 allele was significantly less prevalent in the wet form (P < .0001), but not in the dry form (P = .377). We report a weak association of PON1 Leu55Met with an increased risk of wet AMD, replicating previous reports. Our findings indicate a protective role for Gln192Arg, particularly for patients with the wet form. Gln192Glu warrants consideration, as this variant alters the same amino acid as Gln192Arg and was identified only in category 4 AMD patients. We believe that Met127Arg, His155Arg, and Ala252Gly play minor roles in AMD susceptibility because of their limited frequency and/or location within the PON1 gene. The functional and biological mechanism by which Gln192Arg is acting to decrease AMD susceptibility remains to be determined." @default.
• W1976490669 created "2016-06-24" @default.
• W1976490669 creator A5024098227 @default.
• W1976490669 creator A5024900490 @default.
• W1976490669 creator A5038272073 @default.
• W1976490669 creator A5057084678 @default.
• W1976490669 date "2010-03-01" @default.
• W1976490669 modified "2023-10-18" @default.
• W1976490669 title "Protective Effect of Paraoxonase 1 Gene Variant Gln192Arg in Age-Related Macular Degeneration" @default.
• W1976490669 cites W1487528435 @default.
• W1976490669 cites W1968731162 @default.
• W1976490669 cites W1986531295 @default.
• W1976490669 cites W1997288094 @default.
• W1976490669 cites W2003875995 @default.
• W1976490669 cites W2008578311 @default.
• W1976490669 cites W2008600234 @default.
• W1976490669 cites W2015635131 @default.
• W1976490669 cites W2016469994 @default.
• W1976490669 cites W2017181323 @default.
• W1976490669 cites W2030964561 @default.
• W1976490669 cites W2038166622 @default.
• W1976490669 cites W2040764095 @default.
• W1976490669 cites W2050813368 @default.
• W1976490669 cites W2065430467 @default.
• W1976490669 cites W2082887801 @default.
• W1976490669 cites W2090568412 @default.
• W1976490669 cites W2092067960 @default.
• W1976490669 cites W2092913820 @default.
• W1976490669 cites W2101154649 @default.
• W1976490669 cites W2105479207 @default.
• W1976490669 cites W2109372707 @default.
• W1976490669 cites W2113784410 @default.
• W1976490669 cites W2115139514 @default.
• W1976490669 cites W2117386992 @default.
• W1976490669 cites W2123943285 @default.
• W1976490669 cites W2125236492 @default.
• W1976490669 cites W2128222819 @default.
• W1976490669 cites W2144839999 @default.
• W1976490669 cites W2152389566 @default.
• W1976490669 cites W2162618225 @default.
• W1976490669 cites W2169664803 @default.
• W1976490669 cites W2172238469 @default.
• W1976490669 cites W2309997197 @default.
• W1976490669 cites W2598520882 @default.
• W1976490669 cites W3145351529 @default.
• W1976490669 cites W4237101427 @default.
• W1976490669 cites W4361741482 @default.
• W1976490669 doi "https://doi.org/10.1016/j.ajo.2009.09.024" @default.
• W1976490669 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3026437" @default.
• W1976490669 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20042177" @default.
• W1976490669 hasPublicationYear "2010" @default.
• W1976490669 type Work @default.
• W1976490669 sameAs 1976490669 @default.
• W1976490669 citedByCount "23" @default.
• W1976490669 countsByYear W19764906692012 @default.
• W1976490669 countsByYear W19764906692013 @default.
• W1976490669 countsByYear W19764906692014 @default.
• W1976490669 countsByYear W19764906692015 @default.
• W1976490669 countsByYear W19764906692016 @default.
• W1976490669 countsByYear W19764906692020 @default.
• W1976490669 countsByYear W19764906692021 @default.
• W1976490669 countsByYear W19764906692022 @default.
• W1976490669 crossrefType "journal-article" @default.
• W1976490669 hasAuthorship W1976490669A5024098227 @default.
• W1976490669 hasAuthorship W1976490669A5024900490 @default.
• W1976490669 hasAuthorship W1976490669A5038272073 @default.
• W1976490669 hasAuthorship W1976490669A5057084678 @default.
• W1976490669 hasBestOaLocation W19764906692 @default.
• W1976490669 hasConcept C104317684 @default.
• W1976490669 hasConcept C118487528 @default.
• W1976490669 hasConcept C126322002 @default.
• W1976490669 hasConcept C135763542 @default.
• W1976490669 hasConcept C180754005 @default.
• W1976490669 hasConcept C2776151105 @default.
• W1976490669 hasConcept C2776403814 @default.
• W1976490669 hasConcept C2776509667 @default.
• W1976490669 hasConcept C2908647359 @default.
• W1976490669 hasConcept C37501387 @default.
• W1976490669 hasConcept C501734568 @default.
• W1976490669 hasConcept C54355233 @default.
• W1976490669 hasConcept C71924100 @default.
• W1976490669 hasConcept C75563809 @default.
• W1976490669 hasConcept C86803240 @default.
• W1976490669 hasConcept C99454951 @default.
• W1976490669 hasConceptScore W1976490669C104317684 @default.
• W1976490669 hasConceptScore W1976490669C118487528 @default.
• W1976490669 hasConceptScore W1976490669C126322002 @default.
• W1976490669 hasConceptScore W1976490669C135763542 @default.
• W1976490669 hasConceptScore W1976490669C180754005 @default.
• W1976490669 hasConceptScore W1976490669C2776151105 @default.
• W1976490669 hasConceptScore W1976490669C2776403814 @default.
• W1976490669 hasConceptScore W1976490669C2776509667 @default.
• W1976490669 hasConceptScore W1976490669C2908647359 @default.
• W1976490669 hasConceptScore W1976490669C37501387 @default.
• W1976490669 hasConceptScore W1976490669C501734568 @default.
• W1976490669 hasConceptScore W1976490669C54355233 @default.
• W1976490669 hasConceptScore W1976490669C71924100 @default.
• W1976490669 hasConceptScore W1976490669C75563809 @default.

• next